文献速递临床试验与 GCP

银质针疗法治疗慢性非特异性下背痛:前瞻性单中心随机平行对照临床试验

Efficacy of silver needle therapy for the treatment of chronic nonspecific low back pain: a prospective, single-center, randomized, parallel-controlled clinical trial.
PubMed 文献 · Trials · 2021-01-21

该研究将100例慢性非特异性下背痛患者随机分为银质针组和对照组,每组50例,银质针组接受银质针疗法联合物理治疗,对照组仅接受物理治疗。结果显示两组治疗后2周至6个月多项指标均改善,银质针组在疼痛评分和部分生活质量评分上优于对照组,且无严重并发症。

要点

  • 银质针联合物理治疗可缓解慢性非特异性下背痛并改善生活质量。
  • 银质针组在1、2、3、6个月疼痛评分及1、2个月功能障碍评分优于对照组。
  • 银质针组3、6个月心率变异性指标高于对照组,提示自主神经改善。

核心结论

  • 银质针疗法可缓解慢性非特异性下背痛患者疼痛,改善生活质量和自主神经活动尤其是副交感神经活动,且无严重并发症。

研究设计与样本

  • 前瞻性、单中心、随机、平行对照临床试验,共纳入100例慢性非特异性下背痛患者,随机分为银质针组和对照组各50例。
  • 银质针组接受银质针疗法联合物理治疗,对照组仅接受物理治疗,随访至6个月。

主要发现

  • 两组治疗后2周NRS、ODI、SF-12评分及心率变异性均改善并维持至6个月。
  • 银质针组在1、2、3、6个月NRS和SF-12评分及1、2个月ODI评分较对照组改善更显著(P<0.05)。
  • 两组3个月和6个月ODI评分无显著差异。
  • 银质针组3个月和6个月InLF和InHF高于对照组(P<0.05)。

关键数值与推荐

  • 银质针组在1、2、3、6个月NRS和SF-12评分及1、2个月ODI评分较对照组改善更显著(P<0.05)。
  • 银质针组3个月和6个月InLF和InHF高于对照组(P<0.05)。
  • 两组3个月和6个月ODI评分无显著差异。

临床怎么用

  • 对于慢性非特异性下背痛患者,可考虑在物理治疗基础上联合银质针疗法以改善疼痛和生活质量。

局限性

  • 本研究为单中心设计,样本量100例,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic nonspecific low back pain (CNSLBP) troubles approximately 30% of people worldwide. Silver needle therapy (SNT) is a treatment method to relieve soft tissue pain through heating. Therefore, this study aimed to observe the effects of SNT on CNSLBP. METHODS: In this study, 100 patients were randomly divided into 2 groups: silver needle (SN) group and control group (n = 50). In the SN group, patients received SNT and physiotherapy, while patients received physiotherapy alone in the control group. At the 6-month follow-up, the numerical rating scale (NRS), Oswestry Disability Index (ODI), Short-Form 12 of quality of life (SF-12), the natural logarithms of low-frequency measurement (InLF), and the natural logarithms of high-frequency measurement (InHF) of heart rate variability (HRV) were recorded. RESULTS: In both groups, NRS, ODI, SF-12 scores, and HRV at 2 weeks after treatment were improved and maintained for 6 months. Compared with the control group, more significant improvements were observed in the NRS and SF-12 scores at 1, 2, 3, and 6 months and in the ODI scores at 1 and 2 months in the SN group (P < 0.05). However, there was no significant difference between the groups in the ODI scores at 3 and 6 months. InLF and InHF in the SN group were higher than those in the control group at 3 and 6 months (P < 0.05). CONCLUSIONS: SNT relieved pain and improved quality of life and autonomic nerve activity, especially parasympathetic nerve, in patients with CNSLBP, without serious complications. TRIAL REGISTRATION: Chinese Clinical Trial Registry No. ChiCTR-OOC-17013237 . Registered on November 11, 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Hu X, Dong S, Zhang B, et al. Efficacy of silver needle therapy for the treatment of chronic nonspecific low back pain: a prospective, single-center, randomized, parallel-controlled clinical trial. Trials. 2021. PMID: 33478570. doi:10.1186/s13063-021-05040-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。